Active • Host: HEK293 cells • Tag: C-terminal His • AA: 19-139 • MW: 15.2 kDa
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

CD47 (human, recombinant)

Item No. 32085

Technical Information
Synonyms
  • IAP
  • Integrin-associated Protein
  • Integrin-associated Signal Transducer
  • Leukocyte Surface Antigen CD47
Purity
≥95% as determined by SDS-PAGE
Endotoxin Testing
<1.0 EU/μg, determined by the LAL endotoxin assay
Source
Active recombinant human C-terminal His-tagged CD47 expressed in HEK293 cells
Amino Acids
19-139
MW
15.2 kDa
Lyophilized from sterile PBS, pH 7.4
UniProt Accession №
Q08722
Shipping & Storage Information
Storage
-80°C
Shipping
Dry ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    CD47 is a transmembrane protein and ligand for signal regulatory protein α (SIRPα; Item No. 32082) with roles in phagocytosis, cell adhesion, and migration.1 It is composed of five transmembrane regions and a single immunoglobulin-like (Ig-like) domain that interacts with the amino terminus of SIRPα to induce inhibitory signaling and prevent phagocytosis. CD47 is expressed on all cells, including erythrocytes and platelets, but the levels of expression on immune cells fluctuates in an immune status- or disease-dependent manner. It interacts with certain integrins and functions as a receptor for the extracellular matrix protein thrombospondin. CD47 is overexpressed in various cancer cells, and anti-CD47 antibodies enhance macrophage phagocytosis of tumor cells in vitro.2 Cd47-/- mice exhibit defective mucosal repair after intestinal biopsy or intestinal mucosal damage induced by dextran sulfate sodium (DSS; Item No. 23250).3 Knockout of Cd47 also decreases infarct volume and hemispheric swelling in a mouse model of transient focal cerebral ischemia.4 It also decreases sensorimotor function deficits, brain lesion volume, and neutrophil infiltration, as well as increases brain blood vessel density in a mouse model of traumatic brain injury.5 Cayman's CD47 (human, recombinant) protein can be used for ELISA. This protein consists of 132 amino acids, has a calculated molecular weight of 15.2 kDa, and a predicted N-terminus of Gln19 after signal peptide cleavage. By SDS-PAGE, under reducing conditions, the apparent molecular mass of the protein is approximately 40 kDa due to glycosylation.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Barclay, A.N., and Van den Berg, T.K. The interaction between signal regulatory protein alpha (SIRPα) and CD47: Structure, function, and therapeutic target. Annu. Rev. Immunol. 32, 25-50 (2014).

    2. Veillette, A., and Chen, J. SIRPα-CD47 immune checkpoint blockade in anticancer therapy. Trends Immunol. 39(3), 173-184 (2018).

    3. Reed, M.A., Luissint, A.-C., Azcutia, V., et alEpithelial CD47 is critical for mucosal repair in the murine intestine in vivo. Nat. Commun. 10(1), 5004 (2019).

    4. Jin, G., Tsuji, K., Xing, C., et alCD47 gene knockout protects against transient focal cerebral ischemia in mice. Exp. Neurol. 217(1), 165-170 (2009).

    5. Zhao, S., Yu, Z., Liu, Y., et alCD47 deficiency improves neurological outcomes of traumatic brain injury in mice. Neurosci. Lett. 643, 125-130 (2016).